LSO 2023 Federal Pre-Budget Submission
As one of the most innovative sectors in our economy, the life sciences sector holds the key to driving Canada’s economic prosperity and competitiveness, developing medical innovations that keep Canadians healthy and productive, and addressing some of society’s greatest challenges, including climate change and food security. However, taking advantage of these opportunities will require bold action and long-term commitment.
Life Sciences Ontario’s submission to the federal Finance Committee for its 2023 pre-budget consultations makes one key recommendation for the federal government ahead of its next budget: “Expand the scope and ambition of the Biomanufacturing and Life Sciences Strategy beyond pandemic preparedness to focus on creating a globally competitive policy and business environment for life sciences companies, and establish an advisory table, comprised of public and private sector leaders, to inform, guide and report on the implementation of the strategy.”
LSO Pre-Budget Submission to the Ministry of Finance, Government of Canada – February, 2022
LSO’s submission to Finance Canada’s 2022 pre-budget consultations highlights the life sciences sector’s role in Canada’s health and economic security following COVID-19. The submission’s three key recommendations are:
- Implement the Biomanufacturing and Life Sciences Strategy
- Create a working group of leaders in the public, not-for-profit and private sector to guide the implementation of the Biomanufacturing and Life Sciences Strategy (e.g., by reconstituting or reconvening the Health & Biosciences Economic Strategy Table)
- Repeal the PMPRB regulation changes
Life Sciences Ontario submission to CADTH national formulary consultation
The Canadian Agency for Drugs and Technologies in Health (CADTH), recently asked for stakeholders to comment on its proposed framework for a potential pan-Canadian formulary. Stakeholder input will be used to inform a report that will be submitted to Health Canada, shared with provincial and territorial governments, and made publicly available later this year. The aim is to contribute to national pharmacare policy discussions in Canada.
LSO Responds to the PMPRB’S July 2022 Final Guidelines Submission
Read Guidelines Here
LSO Responds to the PMPRB’S June 2020 Draft Guidelines Consultation
Read Response Here.
LSO Pre-Budget Submission- July 29th 2019
Read Submission Here
A Federal Economic Agenda for Ontario – May 2015
Download the report here
LSO Statement on the 2015 Ontario Budget
Download statement
Life Sciences Ontario Reacts to Ontario Health Innovation Council (OHIC) Report – Dec 2014
Download statement
LSO Statement on MaRS – October, 2014
Download statement
The Quebec-Ontario Life Sciences Corridor: One of the top 5 in North America – June, 2014
Download article
Life Sciences Sector Vital for Ontario’s Economic Growth and Health Care System Sustainability – May, 2014
Download statement
Life Sciences Ontario Reacts to Ontario Budget – May, 2014
Download statement
LSO Pre-Budget Submission to the Ministry of Finance, Government of Ontario – February, 2014
Download submission
LSO Response to Industry Canada’s Science & Technology Consultations – January, 2014
Download statement